We are live on ! Find out more
IMPL

Impel Pharmaceuticals Inc. Common Stock

Delisted

IMPL was delisted on the 15th of December, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$1.78M
NA
2
NVP Associates
California
$1.32M
5VM
3
5AM Venture Management
California
$1.24M
VC
4
Vivo Capital
California
$1.24M
VP
5
venBio Partners
California
$1.19M
Vanguard Group
6
Vanguard Group
Pennsylvania
$217K -$2.54K -2,645 -0.5%
LM
7
Lasry Marc
$97.1K -$175K -182,455 -45%
DA
8
DCF Advisers
Connecticut
$76.8K -$120K -125,105 -41%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$74.1K +$16.6K +17,258 +11%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$15.2K
State Street
11
State Street
Massachusetts
$10.8K
BlackRock
12
BlackRock
New York
$9.73K +$4.94K +5,142 +29%
Millennium Management
13
Millennium Management
New York
$9.24K +$20.6K +21,485 New
XT
14
XTX Topco
Cayman Islands
$9.13K +$20.4K +21,222 New
TSS
15
Two Sigma Securities
New York
$8.8K +$19.6K +20,462 New
MP
16
McDonald Partners
Ohio
$8.34K -$768 -800 -4%
EP
17
EPIQ Partners
Minnesota
$7.02K -$2.23K -2,321 -12%
VF
18
Virtu Financial
New York
$7K +$15.5K +16,112 New
RJA
19
Raymond James & Associates
Florida
$6.24K
CAPTRUST Financial Advisors
20
CAPTRUST Financial Advisors
North Carolina
$6.2K
BJL
21
Brighton Jones LLC
Washington
$6.08K
Northern Trust
22
Northern Trust
Illinois
$5.68K
TRCT
23
Tower Research Capital (TRC)
New York
$3.41K +$3.78K +3,936 +98%
LC
24
Lindbrook Capital
California
$1.31K
Morgan Stanley
25
Morgan Stanley
New York
$860